Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781).
Czarnetzki, BM Macher, E Suciu, S Thomas, D Steerenberg, PA Rumke, P
Czarnetzki, BM
Macher, E
Suciu, S
Thomas, D
Steerenberg, PA
Rumke, P
Citations
Altmetric:
Series / Report no.
Open Access
Type
Article
Language
Date of publication
1993
Year of publication
Research Projects
Organizational Units
Journal Issue
Title
Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781).
Translated Title
Published in
Eur J Cancer 1993; 29A:1237-42